Ivermectin’s Role in Preventing the Neurologic Effects of SARS-CoV-2

A question in the comment section: Considering that ivermectin does not cross the blood-brain barrier, what is its role in lessening the neurologic effects of SARS-CoV-2? SARS-CoV-2, the virus that causes COVID-19, can pass thru the protective blood-brain barrier and cause problems like loss of smell and taste and headaches. If not treated early, worse…

13 Reasons Why COVID-19 Cases and Deaths May Increase Again

Update Jan 12, 2023: I added another reason. SARS-CoV-2 variants of concern developed resistance to interferon as the pandemic progressed. Much new information came out recently about SARS-CoV-2, which causes COVID-19, the antivirals prescribed for it, and its “vaccines.” This article aims to increase awareness that SARS-CoV-2 reinfections can happen no matter if they have…

Common Dandelion Prevents SARS-CoV-2 infection in vitro

Extracts from the common dandelion plant can prevent infection of various SARS-CoV-2 variants. That is the result of in vitro studies from two institutions in Germany, the Molecular Preventive Medicine of the University of Freiburg and the Food Chemistry and Molecular Sensory Science of the Technical University of Munich. In the study, extracts from the…

Diseases From SARS-CoV-2 Autoantibodies

This article features a study showing that autoimmune antibody production is greater among older people with severe COVID-19 infection. The study’s findings can help explain the adverse effects of the COVID “vaccines.” Autoantibodies are antibodies that attack the host’s organs to cause inflammation that manifests as autoimmune diseases. The paper is authored by several well-known…

Mental and Neurologic problems after COVID-19 in children and adults

.Lancet Psychiatry published a study measuring the psychiatric and brain neurologic conditions after COVID-19 infection. The authors are from Oxford and Cambridge University in the UK. The findings are essential for clinicians and health policymakers but also laypeople. The study collected 89 million patient records from several countries, including the USA, Australia, the UK, Spain,…

COVID-19: A Risk Factor for RSV

A recently released preprint study shows an increasing number of RSV infections in children during the COVID-19 pandemic. The authors are from Case Western Reserve University, The Center for Clinical Informatics Research and Education, and the National Institute on Drug Abuse, National Institutes of Health. Respiratory syncytial virus (RSV) infections are a common seasonal infection…

SARS-CoV-2 Spike Protein Cause Red Blood cell Clumping and Ivermectin Prevents it

This article features a new study that adds proof that the spike protein of the SARS-CoV-2 virus increases the risk of blood clotting and that ivermectin can prevent it. The authors are from the Aix-Marseille Université, a leading virology center in Marseille, France. The research, SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and…

Occupations with the highest risk for COVID-19

A study shows that other occupations other than health care are at the highest risk of getting COVID-19. The study authors are from the Department of Occupational Medicine at Århus University Hospital in Denmark. 2.4 million employees, 20-69 years of age, were evaluated. Men’s OCCUPATIONS with the highest risk for COVID-19 In men, the largest…

Big study confirms Vitamin D deficiency leads to worse COVID-19

A new study from Spain supports the need for adequate Vitamin D levels to prevent severe COVID-19. Vitamin D is usually associated with preventing osteoporosis and increasing bone strength. However, newer studies show vitamin D’s critical role in fighting infections and improving heart muscle contractility and anti-thrombotic effects. More about the role of vitamin D…

High titers of infectious SARS-CoV-2 in patients who died of COVID-19

A new study revealed high amounts of contagious SARS-CoV-2 viruses in the bodies of patients who died of COVID-19. In some cases, the viruses were still present 13 days after death. The study showed that infectious virus was detected in six of eleven (55%) cases, 4 of 11 (36%) nasopharyngeal swabs, and 9 of 19…

Research on the Omicron spike protein turned into a Gain of Function study

A new study aimed to improve vaccines for the COVID-19 epidemic. The researchers narrowed down the part of the SARS-CoV- 2 that makes it more infectious. However, in doing so, they made a recombinant virus that is more infectious and lethal. The study, Role of spike in the pathogenic and antigenic behavior of SARS-CoV-2 BA.1…

Remission of Hodgkin lymphoma with SARS-CoV-2

This article is unique because it is about a man whose Hodgkin’s lymphoma disappeared after he had COVID-19. Hodgkin’s lymphoma is a cancer of the lymphocytes. A common sign is enlarged lymph nodes all over the body. Case Report The patient is a 61-year-old patient receiving hemodialysis for end-stage renal failure. Before getting sick with…

The Carcinogenic Effects of the SARS-CoV-2

This article is about the ability of SARS-CoV-2, the virus that causes COVID-19, to change the inner workings of the cells to promote cancer formation. It is known that some viruses can cause cancer. Some viruses can control an infected person’s genes, resulting in unrestricted cell proliferation leading to cancer. Tumor Viruses and cancers Human…

Israel study: No increased incidence of myocarditis with COVID-19

This article features a large study showing no increased incidence of myocarditis in those with COVID-19. One of the arguments for getting COVID-19 shots despite the associated myocarditis is that it prevents myocarditis, which is the sequelae of the COVID-19 disease. A large study from Israel published in the Journal of Clinical Medicine shows no…

Colloidal bismuth and NAC inhibit SARS-CoV-2 replication

This article shows that combining two over-the-counter drugs, colloidal bismuth, and NAC, effectively prevents SARS-CoV-2 replication.[1] Even though the study used colloidal bismuth, the authors mentioned that other forms of bismuth, like bismuth subsalicylate, will work the same. Bismuth subsalicylate is the active ingredient in Pepto-Bismol®, while Colloidal Bismuth Salicylate (CBS) is present in De-Nol®…

A new study shows a 100% decreased hospitalization rate with regular ivermectin use

Cureus recently published a peer-reviewed study that showed the effectiveness of ivermectin in decreasing COVID-19 hospitalization among ivermectin users.[1] Kerr et al. conducted the prospective observational study in Itajaí, Brazil, between July 7 and December 2, 2020. A Prospective Observational Study is a study in which the actual (i.e., real-world) experiences of the groups being…

Pepto-Bismol for COVID-19

A small case series about the potential use of bismuth salicylate, the active ingredient in Pepto-Bismol for COVID-19, was recently peer-reviewed and published in Frontiers in Drug Discovery. Pepto-Bismol is an over-the-counter drug for abdominal complaints like nausea, pain, and diarrhea. The active ingredient is bismuth subsalicylate (BSS). In the study, most patients hospitalized with…

Linoleic acid from intermittent fasting may prevent COVID-19

This article features a study that shows how linoleic acid from intermittent fasting can reduce the chances of getting COVID-19. Background The SARS-CoV-2, the virus that causes COVID-19 attaches to human cells using its spike proteins. After attachment, the viruses enter the cells and start replicating. The SARS-CoV-2 spike proteins can be in the open…

The bacteria and fungi isolated from face masks

Research from Kindai University, Osaka, Japan tested commonly worn face masks and isolated several pathogenic bacteria and fungi from them. The study was peer-reviewed and published in Nature on July 18, 2022 The investigation involved 109 participants who wore three types of masks. The majority (78%) wore the non-woven mask, the typical blue mask worn…

Adverse effects of COVID-19 vaccines and measures to prevent them

The Adverse effects of COVID-19 vaccines and measures to prevent them is a letter to the editor. The Virology Journal published it in June 2022. The author is Kenji Yamamoto from the Department of Cardiovascular Surgery, Okamura Memorial Hospital. There are 1,404 research papers under his name. Below is the abstract of the letter. I…